The markets opened lower with the Dow losing 20 points to 17,048 as fewer jobs than expected were added to the nation's economy. Nasdaq slipped 5 points to 4,556.
On the upside
The Food and Drug Administration granted Orphan Drug designation to Prana Biotechnolgy's (Nasdaq: PRAN) Huntington Disease treatment PBT2.
Ambarella (Nasdaq: AMBA) reported higher second quarter earnings and revenue that beat analyst expectations.
Infoblox (NYSE: BLOX) fell to a loss for the fourth quarter but the results were better than expected.
On the downside
Quiksilver (NYSE: ZQK) fell to a greater than expected loss on lower revenue.
Sportswear Holdings will sell its 5.7% stake in Michael Kors (NYSE: KORS) at the discounted price of $76.75 per share.
Gap (NYSE: GPS) disappointed with a greater than expected 2% drop in same store sales last month.
In the broad market, advancing issues edged out decliners by a margin of nearly 10 to 9 on the NYSE while decliners outpaced advancers by 7 to 5 on Nasdaq. The broader S&P 500 eased a point to 1995. Bitcoin lost $4 to $484.
Lower open on disappointing jobs data
September 05, 2014 at 10:42 AM EDT